Indian Drug Manufacturers
- All
- News
- Videos
-
Why Trump's 100% Pharma Tariffs May Not Impact Indian Drugmakers Much
US President Donald Trump has said his administration will impose 100 per cent import tariffs on branded or patented pharmaceutical drugs from October 1, unless the pharma companies have or are building their manufacturing units in America.
-
Trump Declares 100% Tariff On Pharma Imports From October 1, India May Be Hit
US President Donald Trump has announced tariffs of up to 100 per cent on imports of branded and patented pharmaceutical products from October 1. India's pharmaceuticals sector, one of the most dependent domestic industries on trade with America.
-
AI To Help Indian Pharma Industry To Pivot On Innovation, Reach 130 Billion In Size By 2030
Technological advancements like AI, machine learning and precision medicine are set to revolutionise drug discovery, manufacturing and patient care.
-
New Drug-Making Standards For Indian Pharma Firms After Overseas Deaths
Indian pharmaceutical companies must meet new manufacturing standards this year, according to a government notification released on Saturday, although small companies have asked for a delay, citing their debt load.
-
Defer Implementation Of Rules On Generic Drugs: Doctors' Body To Government
The Indian Medical Association (IMA) on Monday demanded that implementation of regulations that make it mandatory for doctors to prescribe generic drugs be deferred, raising concerns over the standard of drugs manufactured i
-
India Eyes New Drugs Law After Deaths Linked To Country-Made Cough Syrups
A new drugs bill will be taken up for consideration next week on rules for importing, manufacturing and selling medicines in India, according to a parliamentary notice on Thursday.
-
New Drug Export Policy Likely After Concerns On India-Made Drugs: Sources
The Union Health Ministry and the Department of Pharmaceuticals are deliberating this new policy, ministry sources said. Suggestions were sought from the Directorate General of Foreign Trade (DGFT) regarding this.
-
"No Contamination Found": Tamil Nadu Official As US Flags Indian Eye Drop
Tamil Nadu's drug regulator has said it found "no contamination" in samples of eye drops manufactured by Chennai-based Global Pharma, which has hit headlines after a US watchdog linked cases of infections, blindness and even deaths to the eye drops.
-
Nepal Blacklists 16 Indian Firms Including Patanjali-Linked Divya Pharmacy
Nepal's drug regulatory authority has blacklisted 16 Indian pharmaceutical companies, including Divya Pharmacy which manufactures Yoga Guru Ramdev's Patanjali products.
-
"Test Solvents": Karnataka Tells Drugmakers After WHO Cough Syrup Alert
Drugs Control Department has directed drug manufacturers that certificate of analysis of glycerin and propylene glycol procured in the last one year should be submitted within seven days
-
India's Zydus Cadila Seeks Nod For Its Covid Vaccine ZyCoV-D
Indian drugmaker Zydus Cadila said on Thursday it has applied to the country's drug regulator for emergency use approval of its COVID-19 vaccine and that it plans to manufacture up to 120 million doses of the shot annually.
-
Hyderabad Pharma Firm Signs Agreement To Make Covid Drug 2-DG
Hyderabad-based Lee Pharma has entered into an agreement with the Indian Institute of Chemical Technology (IICT), a constituent laboratory of CSIR, to manufacture and commercialise 2-DG used to treat Covid patients, a statement said.
-
On Request For Sputnik 5 Vaccine Approval, Panel Seeks More Data: Sources
The Subject Expert Committee (SEC) of the Indian drug regulator has asked pharma giant Dr Reddy's Laboratories, the Indian manufacturer of Sputnik V, the Russia-developed coronavirus vaccine, for more data regarding its application for emergency use approval for the vaccine, sources said.
-
Indian Drugmaker To Pay $50 Million Fine In US For Irregularities
An Indian drug manufacturer has agreed to plead guilty to concealing and destroying records prior to a 2013 US Food and Drug Administration's inspection of its plant and pay USD 50 million in fines and forfeiture, the Department of Justice has announced.
-
Oxford Vaccine Likely To Be First To Get Approval In India, Say Officials
With preparations underway for a possible vaccine-rollout by January, the Indian drug regulator is looking at the UK, which sources believe may give its nod to the Oxford COVID-19 vaccine next week, before deciding on giving emergency use authorisation to the Serum Institute that is manufacturing the shots.
-
Why Trump's 100% Pharma Tariffs May Not Impact Indian Drugmakers Much
US President Donald Trump has said his administration will impose 100 per cent import tariffs on branded or patented pharmaceutical drugs from October 1, unless the pharma companies have or are building their manufacturing units in America.
-
Trump Declares 100% Tariff On Pharma Imports From October 1, India May Be Hit
US President Donald Trump has announced tariffs of up to 100 per cent on imports of branded and patented pharmaceutical products from October 1. India's pharmaceuticals sector, one of the most dependent domestic industries on trade with America.
-
AI To Help Indian Pharma Industry To Pivot On Innovation, Reach 130 Billion In Size By 2030
Technological advancements like AI, machine learning and precision medicine are set to revolutionise drug discovery, manufacturing and patient care.
-
New Drug-Making Standards For Indian Pharma Firms After Overseas Deaths
Indian pharmaceutical companies must meet new manufacturing standards this year, according to a government notification released on Saturday, although small companies have asked for a delay, citing their debt load.
-
Defer Implementation Of Rules On Generic Drugs: Doctors' Body To Government
The Indian Medical Association (IMA) on Monday demanded that implementation of regulations that make it mandatory for doctors to prescribe generic drugs be deferred, raising concerns over the standard of drugs manufactured i
-
India Eyes New Drugs Law After Deaths Linked To Country-Made Cough Syrups
A new drugs bill will be taken up for consideration next week on rules for importing, manufacturing and selling medicines in India, according to a parliamentary notice on Thursday.
-
New Drug Export Policy Likely After Concerns On India-Made Drugs: Sources
The Union Health Ministry and the Department of Pharmaceuticals are deliberating this new policy, ministry sources said. Suggestions were sought from the Directorate General of Foreign Trade (DGFT) regarding this.
-
"No Contamination Found": Tamil Nadu Official As US Flags Indian Eye Drop
Tamil Nadu's drug regulator has said it found "no contamination" in samples of eye drops manufactured by Chennai-based Global Pharma, which has hit headlines after a US watchdog linked cases of infections, blindness and even deaths to the eye drops.
-
Nepal Blacklists 16 Indian Firms Including Patanjali-Linked Divya Pharmacy
Nepal's drug regulatory authority has blacklisted 16 Indian pharmaceutical companies, including Divya Pharmacy which manufactures Yoga Guru Ramdev's Patanjali products.
-
"Test Solvents": Karnataka Tells Drugmakers After WHO Cough Syrup Alert
Drugs Control Department has directed drug manufacturers that certificate of analysis of glycerin and propylene glycol procured in the last one year should be submitted within seven days
-
India's Zydus Cadila Seeks Nod For Its Covid Vaccine ZyCoV-D
Indian drugmaker Zydus Cadila said on Thursday it has applied to the country's drug regulator for emergency use approval of its COVID-19 vaccine and that it plans to manufacture up to 120 million doses of the shot annually.
-
Hyderabad Pharma Firm Signs Agreement To Make Covid Drug 2-DG
Hyderabad-based Lee Pharma has entered into an agreement with the Indian Institute of Chemical Technology (IICT), a constituent laboratory of CSIR, to manufacture and commercialise 2-DG used to treat Covid patients, a statement said.
-
On Request For Sputnik 5 Vaccine Approval, Panel Seeks More Data: Sources
The Subject Expert Committee (SEC) of the Indian drug regulator has asked pharma giant Dr Reddy's Laboratories, the Indian manufacturer of Sputnik V, the Russia-developed coronavirus vaccine, for more data regarding its application for emergency use approval for the vaccine, sources said.
-
Indian Drugmaker To Pay $50 Million Fine In US For Irregularities
An Indian drug manufacturer has agreed to plead guilty to concealing and destroying records prior to a 2013 US Food and Drug Administration's inspection of its plant and pay USD 50 million in fines and forfeiture, the Department of Justice has announced.
-
Oxford Vaccine Likely To Be First To Get Approval In India, Say Officials
With preparations underway for a possible vaccine-rollout by January, the Indian drug regulator is looking at the UK, which sources believe may give its nod to the Oxford COVID-19 vaccine next week, before deciding on giving emergency use authorisation to the Serum Institute that is manufacturing the shots.
